A Randomized, Double-Blind, Placebo-controlled Study of SD-809 (Dutetrabenazine) for the Treatement of Moderate to Severe Tardive Dyskinesia
Clinical Trial Grant
Administered By
Neurology, Movement Disorders
Awarded By
Auspex Pharmaceuticals, Inc.
Start Date
July 1, 2014
End Date
June 30, 2016
Administered By
Neurology, Movement Disorders
Awarded By
Auspex Pharmaceuticals, Inc.
Start Date
July 1, 2014
End Date
June 30, 2016